Aurobindo Pharma jumps on incorporating wholly owned subsidiary

Aurobindo Pharma rises on getting final nod for Dapagliflozin, Metformin Hydrochloride Extended-Release Tablets

Mumbai, February 26 (Udaipur Kiran): Aurobindo Pharma is currently trading at Rs. 1222.95, up by 8.95 points or 0.74% from its previous closing of Rs. 1214.00 on the BSE. The scrip opened at Rs. 1214.10 and has touched a high and low of Rs. 1250.85 and Rs. 1214.00 respectively. So far 214614 shares were traded … Read more

BREAKING NEWS:
“Govinda’s niece trolled for bikini look, loses followers!” 150-inch screen for ₹7,999: Lifelong mini projector launched! Jio launches new 31-day recharge plan at ₹339!